GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | 10/30/2026 7:53:07 AM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $17,404,000,000 +10.3% | Export Earnings Model | |||
| AbbVie Inc. (ABBV) | 10/5/2026 4:10:18 PM | View | Guidance Update | SEC | Y 2026 | ||||||
| AbbVie Inc. (ABBV) | 8/3/2026 2:24:26 PM | Large | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $16,990,000,000 +10.2% | Assets $135,115,000,000 | EPS $2.03 | |
| AbbVie Inc. (ABBV) | 7/31/2026 7:52:21 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $16,990,000,000 +10.2% | Assets $135,115,000,000 | EPS $2.03 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 7/6/2026 4:13:31 PM | View | Guidance Update | SEC | 3Q 2026 | ||||||
| AbbVie Inc. (ABBV) | 5/8/2026 12:32:58 PM | Large | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $15,002,000,000 +12.4% | Assets $136,463,000,000 | EPS $0.39 | |
| AbbVie Inc. (ABBV) | 4/29/2026 7:50:59 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $15,002,000,000 +12.4% | Assets $136,463,000,000 | EPS $0.39 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 4/3/2026 4:06:30 PM | View | Guidance Update | SEC | 2Q 2026 | ||||||
| AbbVie Inc. (ABBV) | 3/23/2026 5:00:28 PM | View | Proxy | SEC | Y 2025 | ||||||
| AbbVie Inc. (ABBV) | 2/20/2026 2:44:17 PM | Large | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $61,160,000,000 +8.6% | Assets $133,960,000,000 | EPS $2.36 | |
| AbbVie Inc. (ABBV) | 2/4/2026 7:55:59 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $16,618,000,000 +10.0% | Assets $133,960,000,000 | EPS $1.02 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 1/7/2026 4:10:32 PM | View | Guidance Update | SEC | 1Q 2026 | ||||||
| AbbVie Inc. (ABBV) | 11/4/2025 2:13:56 PM | Large | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $15,776,000,000 +9.1% | Assets $133,898,000,000 | EPS $0.10 | |
| AbbVie Inc. (ABBV) | 10/31/2025 7:52:26 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $15,776,000,000 +9.1% | Assets $133,898,000,000 | EPS $0.10 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 10/3/2025 4:10:10 PM | View | Guidance Update | SEC | Y 2025 | ||||||
| AbbVie Inc. (ABBV) | 8/4/2025 3:25:21 PM | Large | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $15,423,000,000 +6.6% | Assets $137,182,000,000 | EPS $0.52 | |
| AbbVie Inc. (ABBV) | 7/31/2025 7:49:46 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $15,423,000,000 +6.6% | Assets $137,182,000,000 | EPS $0.52 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 7/3/2025 1:09:47 PM | View | Guidance Update | SEC | Y 2025 | ||||||
| AbbVie Inc. (ABBV) | 5/9/2025 1:34:20 PM | Large | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $13,343,000,000 +8.4% | Assets $136,165,000,000 | EPS $0.72 | |
| AbbVie Inc. (ABBV) | 4/25/2025 7:49:33 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $13,343,000,000 +8.4% | Assets $136,165,000,000 | EPS $0.72 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 4/3/2025 4:22:28 PM | View | Guidance Update | SEC | Y 2025 | ||||||
| AbbVie Inc. (ABBV) | 3/24/2025 4:29:02 PM | View | Proxy | SEC | Y 2024 | ||||||
| AbbVie Inc. (ABBV) | 2/14/2025 1:26:01 PM | Large | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $56,334,000,000 +3.7% | Assets $135,161,000,000 | EPS $2.39 | |
| AbbVie Inc. (ABBV) | 1/31/2025 7:43:38 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $15,102,000,000 +5.6% | Assets $135,161,000,000 | EPS -$0.02 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 1/6/2025 4:04:28 PM | View | Guidance Update | SEC | Y 2025 | ||||||
| AbbVie Inc. (ABBV) | 11/4/2024 2:30:09 PM | Large | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $14,460,000,000 +3.8% | Assets $143,422,000,000 | EPS $0.88 | |
| AbbVie Inc. (ABBV) | 10/30/2024 7:43:55 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $14,460,000,000 +3.8% | Assets $143,422,000,000 | EPS $0.88 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 10/3/2024 4:09:03 PM | View | Guidance Update | SEC | Y 2024 | ||||||
| AbbVie Inc. (ABBV) | 8/7/2024 3:18:45 PM | Large | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $14,462,000,000 +4.3% | Assets $141,937,000,000 | EPS $0.77 | |
| AbbVie Inc. (ABBV) | 7/25/2024 7:42:28 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $14,462,000,000 +4.3% | Assets $141,937,000,000 | EPS $0.77 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 7/3/2024 2:09:17 PM | View | Guidance Update | SEC | Y 2024 | ||||||
| AbbVie Inc. (ABBV) | 5/3/2024 11:17:47 AM | Large | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $12,310,000,000 +0.7% | Assets $148,874,000,000 | EPS $0.77 | |
| AbbVie Inc. (ABBV) | 4/26/2024 7:44:46 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $12,310,000,000 +0.7% | Assets $148,874,000,000 | EPS $0.77 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 4/3/2024 4:08:35 PM | View | Financials | Earnings (Prelim) | SEC | 1Q 2024 | Export Earnings Model | ||||
| AbbVie Inc. (ABBV) | 3/18/2024 4:17:00 PM | View | Proxy | SEC | Y 2023 | ||||||
| AbbVie Inc. (ABBV) | 2/20/2024 12:55:14 PM | Large | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $54,318,000,000 -6.4% | Assets $134,711,000,000 | EPS $2.72 | |
| AbbVie Inc. (ABBV) | 2/2/2024 7:51:53 AM | View | Financials | Earnings | SEC | Y 2023 | Rev $14,301,000,000 -5.4% | Assets $134,711,000,000 | EPS $0.46 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 1/5/2024 4:05:02 PM | View | Guidance Update | SEC | Y 2024 | ||||||
| AbbVie Inc. (ABBV) | 11/6/2023 1:16:37 PM | Large | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $13,927,000,000 -6.0% | Assets $136,221,000,000 | EPS $1.00 | |
| AbbVie Inc. (ABBV) | 10/27/2023 7:51:15 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $13,927,000,000 -6.0% | Assets $136,221,000,000 | EPS $1.00 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 10/4/2023 4:12:37 PM | View | Financials | Earnings (Prelim) | SEC | 3Q 2023 | Export Earnings Model | ||||
| AbbVie Inc. (ABBV) | 8/7/2023 1:28:36 PM | Large | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $13,865,000,000 -4.9% | Assets $135,367,000,000 | EPS $1.14 | |
| AbbVie Inc. (ABBV) | 7/27/2023 7:46:25 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $13,865,000,000 -4.9% | Assets $135,367,000,000 | EPS $1.14 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 7/6/2023 4:19:40 PM | View | Guidance Update | SEC | Y 2023 | ||||||
| AbbVie Inc. (ABBV) | 5/5/2023 1:12:36 PM | Large | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $12,225,000,000 -9.7% | Assets $134,544,000,000 | EPS $0.13 | |
| AbbVie Inc. (ABBV) | 4/27/2023 7:37:58 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $12,225,000,000 -9.7% | Assets $134,544,000,000 | EPS $0.13 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 4/5/2023 4:35:34 PM | View | Guidance Update | SEC | Y 2023 | ||||||
| AbbVie Inc. (ABBV) | 3/20/2023 5:02:11 PM | View | Proxy | SEC | Y 2022 | ||||||
| AbbVie Inc. (ABBV) | 2/17/2023 1:07:53 PM | Large | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $58,054,000,000 +3.3% | Assets $138,805,000,000 | EPS $6.63 | |
| AbbVie Inc. (ABBV) | 2/9/2023 7:56:57 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $15,121,000,000 +1.6% | Assets $138,805,000,000 | EPS $1.38 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 1/6/2023 4:17:30 PM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| AbbVie Inc. (ABBV) | 11/4/2022 1:16:45 PM | Large | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $14,812,000,000 +3.3% | Assets $141,325,000,000 | EPS $2.21 | |
| AbbVie Inc. (ABBV) | 10/28/2022 7:49:30 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $14,812,000,000 +3.3% | Assets $141,325,000,000 | EPS $2.21 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 10/5/2022 4:15:58 PM | View | Guidance Update | SEC | Y 2022 | ||||||
| AbbVie Inc. (ABBV) | 8/4/2022 4:05:58 PM | Large | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $14,583,000,000 +4.5% | Assets $143,186,000,000 | EPS $0.51 | |
| AbbVie Inc. (ABBV) | 7/29/2022 7:50:33 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $14,583,000,000 +4.5% | Assets $143,186,000,000 | EPS $0.51 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 7/6/2022 4:19:29 PM | View | Guidance Update | SEC | Y 2022 | ||||||
| AbbVie Inc. (ABBV) | 5/6/2022 1:10:06 PM | Large | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $13,538,000,000 +4.1% | Assets $143,211,000,000 | EPS $2.51 | |
| AbbVie Inc. (ABBV) | 4/29/2022 7:46:58 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $13,538,000,000 +4.1% | Assets $143,211,000,000 | EPS $2.51 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 4/21/2022 5:14:04 PM | View | Financials | Earnings (Prelim) | SEC | 1Q 2022 | Export Earnings Model | ||||
| AbbVie Inc. (ABBV) | 3/21/2022 5:02:57 PM | View | Proxy | SEC | Y 2021 | ||||||
| AbbVie Inc. (ABBV) | 2/18/2022 12:52:05 PM | Large | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $56,197,000,000 +22.7% | Assets $146,529,000,000 | EPS $6.45 | |
| AbbVie Inc. (ABBV) | 2/2/2022 7:49:45 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $14,886,000,000 +7.4% | Assets $146,529,000,000 | EPS $2.26 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 11/2/2021 1:03:13 PM | Large | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $14,342,000,000 +11.2% | Assets $148,858,000,000 | EPS $1.78 | |
| AbbVie Inc. (ABBV) | 10/29/2021 7:44:49 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $14,342,000,000 +11.2% | Assets $148,858,000,000 | EPS $1.78 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 8/2/2021 1:32:50 PM | Large | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $13,959,000,000 +33.9% | Assets $147,972,000,000 | EPS $0.42 | |
| AbbVie Inc. (ABBV) | 7/30/2021 7:53:31 AM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $13,959,000,000 +33.9% | Assets $147,972,000,000 | EPS $0.42 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 5/7/2021 10:23:48 AM | Large | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $13,010,000,000 +50.9% | Assets $150,501,000,000 | EPS $1.99 | |
| AbbVie Inc. (ABBV) | 4/30/2021 7:46:47 AM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $13,010,000,000 +50.9% | Assets $150,501,000,000 | EPS $1.99 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 3/22/2021 5:02:41 PM | View | Proxy | SEC | Y 2020 | ||||||
| AbbVie Inc. (ABBV) | 2/19/2021 2:13:26 PM | Large | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $45,804,000,000 +37.7% | Assets $150,565,000,000 | EPS $2.72 | |
| AbbVie Inc. (ABBV) | 2/3/2021 7:42:49 AM | View | Financials | Earnings | SEC | Y 2020 | Rev $13,858,000,000 +59.2% | Assets $150,565,000,000 | EPS $0.01 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 11/4/2020 10:07:26 AM | Large | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $12,902,000,000 +52.2% | Assets $149,621,000,000 | EPS $1.29 | |
| AbbVie Inc. (ABBV) | 10/30/2020 7:53:17 AM | View | Financials | Earnings | SEC | 3Q 2020 | Rev $12,902,000,000 +52.2% | Assets $149,621,000,000 | EPS $1.29 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 8/4/2020 10:07:23 AM | Large | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $10,425,000,000 +26.3% | Assets $149,530,000,000 | EPS -$0.46 | |
| AbbVie Inc. (ABBV) | 7/31/2020 8:44:28 AM | View | Financials | Earnings | SEC | 2Q 2020 | Rev $10,425,000,000 +26.3% | Assets $149,530,000,000 | EPS -$0.46 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 5/8/2020 6:24:33 AM | Large | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $8,619,000,000 +10.1% | Assets $91,199,000,000 | EPS $2.02 | |
| AbbVie Inc. (ABBV) | 5/1/2020 7:45:38 AM | View | Financials | Earnings | SEC | 1Q 2020 | Rev $8,619,000,000 +10.1% | Assets $91,199,000,000 | EPS $2.02 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 3/23/2020 5:23:46 PM | View | Proxy | SEC | Y 2019 | ||||||
| AbbVie Inc. (ABBV) | 2/21/2020 11:04:07 AM | Large | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $33,266,000,000 +1.6% | Assets $89,115,000,000 | EPS $5.28 | |
| AbbVie Inc. (ABBV) | 2/7/2020 7:49:15 AM | View | Financials | Earnings | SEC | Y 2019 | Rev $8,704,000,000 +4.8% | Assets $89,115,000,000 | EPS $1.88 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 11/6/2019 11:25:49 AM | Large | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $8,479,000,000 +3.0% | Assets $59,441,000,000 | EPS $1.26 | |
| AbbVie Inc. (ABBV) | 11/1/2019 7:51:45 AM | View | Financials | Earnings | SEC | 3Q 2019 | Rev $8,479,000,000 +3.0% | Assets $59,441,000,000 | EPS $1.26 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 8/5/2019 12:47:40 PM | Large | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $8,255,000,000 -0.3% | Assets $57,142,000,000 | EPS $0.49 | |
| AbbVie Inc. (ABBV) | 7/26/2019 7:44:49 AM | View | Financials | Earnings | SEC | 2Q 2019 | Rev $8,255,000,000 -0.3% | Assets $57,142,000,000 | EPS $0.49 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 5/3/2019 10:47:47 AM | Large | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $7,828,000,000 -1.3% | Assets $56,769,000,000 | EPS $1.65 | |
| AbbVie Inc. (ABBV) | 4/25/2019 7:46:07 AM | View | Financials | Earnings | SEC | 1Q 2019 | Rev $7,828,000,000 -1.3% | Assets $56,769,000,000 | EPS $1.65 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 3/22/2019 4:38:29 PM | View | Proxy | SEC | Y 2018 | ||||||
| AbbVie Inc. (ABBV) | 2/27/2019 5:02:19 PM | Large | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $32,753,000,000 +16.1% | Assets $59,352,000,000 | EPS $3.66 | |
| AbbVie Inc. (ABBV) | 1/25/2019 7:47:17 AM | View | Financials | Earnings | SEC | Y 2018 | Rev $8,305,000,000 +7.3% | Assets $59,352,000,000 | EPS -$1.23 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 11/7/2018 12:57:00 PM | Large | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $8,236,000,000 +17.7% | Assets $66,164,000,000 | EPS $1.81 | |
| AbbVie Inc. (ABBV) | 11/2/2018 7:51:57 AM | View | Financials | Earnings | SEC | 3Q 2018 | Rev $8,236,000,000 +17.7% | Assets $66,164,000,000 | EPS $1.81 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 8/7/2018 1:35:18 PM | Large | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $8,278,000,000 +19.2% | Assets $61,641,000,000 | EPS $1.26 | |
| AbbVie Inc. (ABBV) | 7/27/2018 7:44:51 AM | View | Financials | Earnings | SEC | 2Q 2018 | Rev $8,278,000,000 +19.2% | Assets $61,641,000,000 | EPS $1.26 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 5/4/2018 11:16:00 AM | Large | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $7,934,000,000 +21.4% | Assets $69,342,000,000 | EPS $1.74 | |
| AbbVie Inc. (ABBV) | 4/26/2018 7:54:04 AM | View | Financials | Earnings | SEC | 1Q 2018 | Rev $7,934,000,000 +21.4% | Assets $69,342,000,000 | EPS $1.74 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 3/19/2018 4:51:59 PM | View | Proxy | SEC | Y 2017 | ||||||
| AbbVie Inc. (ABBV) | 2/16/2018 12:51:23 PM | Large | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $28,216,000,000 +10.1% | Assets $70,786,000,000 | EPS $3.30 | |
| AbbVie Inc. (ABBV) | 1/26/2018 7:54:14 AM | View | Financials | Earnings | SEC | Y 2017 | Rev $7,739,000,000 +13.9% | Assets $70,786,000,000 | EPS $0.03 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 11/7/2017 11:40:43 AM | Large | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $6,995,000,000 +8.8% | Assets $68,840,000,000 | EPS $1.01 | |
| AbbVie Inc. (ABBV) | 10/27/2017 7:43:33 AM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $6,995,000,000 +8.8% | Assets $68,840,000,000 | EPS $1.01 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 8/7/2017 12:36:29 PM | Large | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $6,944,000,000 +7.6% | Assets $66,994,000,000 | EPS $1.19 | |
| AbbVie Inc. (ABBV) | 7/28/2017 7:45:49 AM | View | Financials | Earnings | SEC | 2Q 2017 | Rev $6,944,000,000 +7.6% | Assets $66,994,000,000 | EPS $1.19 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 5/5/2017 10:26:56 AM | Large | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $6,538,000,000 +9.7% | Assets $65,664,000,000 | EPS $1.06 | |
| AbbVie Inc. (ABBV) | 4/27/2017 7:42:17 AM | View | Financials | Earnings | SEC | 1Q 2017 | Rev $6,538,000,000 +9.7% | Assets $65,664,000,000 | EPS $1.06 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 3/20/2017 12:42:10 PM | View | Proxy | SEC | Y 2016 | ||||||
| AbbVie Inc. (ABBV) | 2/17/2017 12:19:05 PM | Large | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $25,638,000,000 +12.2% | Assets $66,099,000,000 | EPS $3.63 | |
| AbbVie Inc. (ABBV) | 1/27/2017 7:53:38 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $6,796,000,000 +6.2% | Assets $66,099,000,000 | EPS $0.85 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 11/7/2016 12:52:37 PM | Large | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $6,432,000,000 +8.2% | Assets $66,626,000,000 | EPS $0.97 | |
| AbbVie Inc. (ABBV) | 10/28/2016 7:55:17 AM | View | Financials | Earnings | SEC | 3Q 2016 | Rev $6,432,000,000 +8.2% | Assets $66,626,000,000 | EPS $0.97 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 8/5/2016 12:24:41 PM | Large | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $6,452,000,000 +17.8% | Assets $67,211,000,000 | EPS $0.98 | |
| AbbVie Inc. (ABBV) | 7/29/2016 7:43:59 AM | View | Financials | Earnings | SEC | 2Q 2016 | Rev $6,452,000,000 +17.8% | Assets $67,211,000,000 | EPS $0.98 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 5/6/2016 12:22:19 PM | Large | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $5,958,000,000 +18.2% | Assets $53,720,000,000 | EPS $0.83 | |
| AbbVie Inc. (ABBV) | 4/28/2016 7:26:18 AM | View | Financials | Earnings | SEC | 1Q 2016 | Rev $5,958,000,000 +18.2% | Assets $53,720,000,000 | EPS $0.83 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 3/21/2016 1:48:30 PM | View | Proxy | SEC | Y 2015 | ||||||
| AbbVie Inc. (ABBV) | 2/19/2016 12:32:59 PM | Large | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $22,859,000,000 +14.5% | Assets $53,050,000,000 | EPS $3.13 | |
| AbbVie Inc. (ABBV) | 1/29/2016 7:53:53 AM | View | Financials | Earnings | SEC | Y 2015 | Rev $6,400,000,000 +17.4% | Assets $53,050,000,000 | EPS $0.92 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 11/6/2015 1:40:18 PM | Large | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $5,944,000,000 +18.4% | Assets $54,832,000,000 | EPS $0.74 | |
| AbbVie Inc. (ABBV) | 10/30/2015 7:03:18 AM | View | Financials | Earnings | SEC | 3Q 2015 | Rev $5,944,000,000 +18.4% | Assets $54,832,000,000 | EPS $0.74 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 8/7/2015 1:58:41 PM | Large | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $5,475,000,000 +11.1% | Assets $53,855,000,000 | EPS $0.83 | |
| AbbVie Inc. (ABBV) | 7/24/2015 8:10:39 AM | View | Financials | Earnings | SEC | 2Q 2015 | Rev $5,475,000,000 +11.1% | Assets $53,855,000,000 | EPS $0.83 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 5/8/2015 4:15:17 PM | Large | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $5,040,000,000 +10.5% | Assets $26,699,000,000 | EPS $0.63 | |
| AbbVie Inc. (ABBV) | 4/23/2015 7:59:07 AM | View | Financials | Earnings | SEC | 1Q 2015 | Rev $5,040,000,000 +10.5% | Assets $26,699,000,000 | EPS $0.63 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 3/20/2015 5:07:39 PM | View | Proxy | SEC | Y 2014 | ||||||
| AbbVie Inc. (ABBV) | 2/20/2015 3:18:31 PM | Large | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $19,960,000,000 +6.2% | Assets $27,513,000,000 | EPS $1.10 | |
| AbbVie Inc. (ABBV) | 1/30/2015 7:57:38 AM | View | Financials | Earnings | SEC | Y 2014 | Rev $5,452,000,000 +6.7% | Assets $27,513,000,000 | EPS -$0.51 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 11/7/2014 4:09:36 PM | Large | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $5,019,000,000 +7.8% | Assets $28,454,000,000 | EPS $0.31 | |
| AbbVie Inc. (ABBV) | 10/31/2014 7:56:26 AM | View | Financials | Earnings | SEC | 3Q 2014 | Rev $5,019,000,000 +7.8% | Assets $28,454,000,000 | EPS $0.31 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 8/7/2014 5:03:44 PM | Large | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $4,926,000,000 +5.0% | Assets $29,045,000,000 | EPS $0.68 | |
| AbbVie Inc. (ABBV) | 7/25/2014 7:57:25 AM | View | Financials | Earnings | SEC | 2Q 2014 | Rev $4,926,000,000 +5.0% | Assets $29,045,000,000 | EPS $0.68 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 5/9/2014 2:11:57 PM | Large | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $4,563,000,000 +5.4% | Assets $28,657,000,000 | EPS $0.61 | |
| AbbVie Inc. (ABBV) | 4/25/2014 7:57:30 AM | View | Financials | Earnings | SEC | 1Q 2014 | Rev $4,563,000,000 +5.4% | Assets $28,657,000,000 | EPS $0.61 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 3/24/2014 5:00:05 PM | View | Proxy | SEC | Y 2013 | ||||||
| AbbVie Inc. (ABBV) | 2/21/2014 3:03:44 PM | Large | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $18,790,000,000 +2.2% | Assets $29,198,000,000 | EPS $2.56 | |
| AbbVie Inc. (ABBV) | 1/31/2014 7:51:34 AM | View | Financials | Earnings | SEC | Y 2013 | Rev $5,111,000,000 -1.8% | Assets $29,198,000,000 | EPS $0.70 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 11/12/2013 4:57:14 PM | Large | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $4,658,000,000 +3.3% | Assets $28,252,000,000 | EPS $0.60 | |
| AbbVie Inc. (ABBV) | 10/25/2013 7:57:11 AM | View | Financials | Earnings | SEC | 3Q 2013 | Rev $4,658,000,000 +3.3% | Assets $28,252,000,000 | EPS $0.60 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 8/9/2013 2:48:29 PM | Large | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $4,692,000,000 +4.4% | Assets $27,910,000,000 | EPS $0.66 | |
| AbbVie Inc. (ABBV) | 7/26/2013 7:55:22 AM | View | Financials | Earnings | SEC | 2Q 2013 | Rev $4,692,000,000 +4.4% | Assets $27,910,000,000 | EPS $0.66 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 5/8/2013 4:53:00 PM | Large | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $4,329,000,000 +3.7% | Assets $27,169,000,000 | EPS $0.60 | |
| AbbVie Inc. (ABBV) | 4/26/2013 7:58:15 AM | View | Financials | Earnings | SEC | 1Q 2013 | Rev $4,329,000,000 +3.7% | Assets $27,169,000,000 | EPS $0.60 | Export Earnings Model | |
| AbbVie Inc. (ABBV) | 3/15/2013 4:40:03 PM | View | Proxy | SEC | Y 2012 |